New hope for rare uterine cancer: targeted drug trial launches
Disease control
Recruiting now
This study tests a drug called azenosertib in 25 women whose uterine serous carcinoma has come back or not gone away. The drug blocks a protein (Wee1) that cancer cells need to grow. Researchers will check if the drug slows tumor growth and look at how it affects cancer cells in …
Phase: PHASE2 • Sponsor: Joyce Liu, MD • Aim: Disease control
Last updated May 12, 2026 13:40 UTC